We are live on ! Find out more
ALBO

Albireo Pharma Inc

Delisted

ALBO was delisted on the 2nd of March, 2023.

108 hedge funds and large institutions have $533M invested in Albireo Pharma Inc in 2020 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 37 increasing their positions, 26 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

289% more first-time investments, than exits

New positions opened: 35 | Existing positions closed: 9

96% more capital invested

Capital invested by funds: $272M → $533M (+$261M)

42% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 26

32% more funds holding

Funds holding: 82108 (+26)

86% less call options, than puts

Call options by funds: $7.05M | Put options by funds: $51.1M

Holders
108
Holders Change
+26
Holders Change %
+31.71%
% of All Funds
2.18%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
35
Increased
37
Reduced
26
Closed
9
Calls
$7.05M
Puts
$51.1M
Net Calls
-$44.1M
Net Calls Change
-$47.6M
Name Holding Trade Value Shares
Change
Change in
Stake
California Public Employees Retirement System
51
California Public Employees Retirement System
California
$924K +$23.3K +800 +3%
Simplex Trading
52
Simplex Trading
Illinois
$919K +$588K +20,180 +274%
State of Wisconsin Investment Board
53
State of Wisconsin Investment Board
Wisconsin
$884K +$181K +6,200 +31%
Invesco
54
Invesco
Georgia
$835K +$729K +25,024 New
AA
55
ALPS Advisors
Colorado
$808K +$110K +3,783 +19%
AllianceBernstein
56
AllianceBernstein
Tennessee
$754K +$210K +7,200 +47%
Los Angeles Capital Management
57
Los Angeles Capital Management
California
$697K +$227K +7,780 +59%
SFI
58
Susquehanna Fundamental Investments
Pennsylvania
$697K +$609K +20,900 New
California State Teachers Retirement System (CalSTRS)
59
California State Teachers Retirement System (CalSTRS)
California
$669K +$18.6K +640 +3%
LCM
60
Laurion Capital Management
New York
$667K +$583K +20,000 New
Man Group
61
Man Group
United Kingdom
$611K +$25.2K +865 +5%
Susquehanna International Group
62
Susquehanna International Group
Pennsylvania
$603K -$188K -6,445 -26%
MCM
63
MAI Capital Management
Ohio
$542K -$12.9K -444 -3%
RhumbLine Advisers
64
RhumbLine Advisers
Massachusetts
$533K -$36.8K -1,263 -7%
WMSA
65
Weiss Multi-Strategy Advisers
New York
$501K -$728K -25,000 -63%
MAM
66
Martingale Asset Management
Massachusetts
$492K +$428K +14,700 New
TRCT
67
Tower Research Capital (TRC)
New York
$463K +$327K +11,221 +425%
New York State Common Retirement Fund
68
New York State Common Retirement Fund
New York
$454K
ECM
69
ExodusPoint Capital Management
New York
$413K +$360K +12,370 New
Qube Research & Technologies (QRT)
70
Qube Research & Technologies (QRT)
United Kingdom
$402K +$351K +12,047 New
MFS
71
Mirabella Financial Services
United Kingdom
$366K +$319K +10,968 New
Barclays
72
Barclays
United Kingdom
$334K +$78.6K +2,699 +37%
M&T Bank
73
M&T Bank
New York
$329K
Squarepoint
74
Squarepoint
New York
$315K -$10.5K -362 -4%
Bank of America
75
Bank of America
North Carolina
$314K +$13.8K +473 +5%

ALBO Hedge Fund Activity: Q3 2020 in Review

108 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q3 2020, worth a combined $533M — up 96% from $272M a quarter earlier.

Buyers outnumbered sellers: 35 funds opened new ALBO positions and 9 closed out — a net gain of 26 holders — while 37 added to existing stakes and 26 trimmed.

The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $20.4M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $4.64M sold.

  • 108 institutional investors held Albireo Pharma Inc (ALBO) as of Q3 2020, up from 82 in Q2 2020.
  • Funds reported $533M of Albireo Pharma Inc stock for Q3 2020, up 96% quarter-over-quarter.
  • 35 funds opened new Albireo Pharma Inc positions in Q3 2020 and 9 closed out, a net change of +26 holders.
  • The largest Albireo Pharma Inc buyer in Q3 2020 was Cormorant Asset Management, an estimated $20.4M added.
  • The largest Albireo Pharma Inc seller in Q3 2020 was Point72 Asset Management, an estimated $4.64M sold.

Based on aggregated 13F filings for Q3 2020.